Menu
Recruiting NCT06801938

Evaluation of Perioperative Cystoscopy and Methylene Blue Test in Detecting Complications in TVT and TOT Procedures

No phase Interventional Incontinence Stress

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Perioperative Cystoscopy and Methylene Blue Test.
Who it may be relevant to
Registry conditions: Incontinence Stress. Basic parameters: 18 years — 85 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Comparison of Complications Detected by Perioperative Cystoscopy Combined With Methylene Blue Test and Postoperative Cystoscopy in TVT and TOT Operations

Overview

Comparison of complications detected by perioperative cystoscopy combined with methylene blue test and postoperative cystoscopy in TVT and TOT operations.

Interventions

  • Procedure Perioperative Cystoscopy and Methylene Blue Test
    The ability of perioperative methylene blue and cystoscopy versus postoperative cystoscopy to detect complications will be compared in patients.

Primary outcome measures

  • rate of complication detection [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Providing consent to participate in the study
  • Being between the ages of 18 and 85
  • Having stress urinary incontinence
  • No active cardiac disease
  • No connective tissue disorders (e.g., Marfan syndrome)
  • No known gynecological malignancy
  • BMI under 30
  • No chronic constipation
  • No inflammatory bowel disease

Exclusion criteria

  • Not providing consent to participate in the study
  • Being under 18 or over 85 years old
  • Not having stress urinary incontinence
  • Having active cardiac disease
  • Having connective tissue disorders (e.g., Marfan syndrome)
  • Having a known gynecological malignancy
  • Having a BMI over 30
  • Having chronic constipation
  • Having inflammatory bowel disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Gaziosmanpaşa Training and Research Hospital — Istanbul

Identifiers

NCT: NCT06801938 · GaziosmanpasaTREHfkgfkg

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗